Oncolytic Virus-Based Immunotherapies for Hepatocellular Carcinoma

Figure 1

JX-594 was generated as insertion of human GM-CSF and β-galactosidase at in between early/late promoter of TK gene. GM-CSF is an immune-stimulatory cytokine, which induces immune response against tumor cells.